West Pharmaceutical Services (WST) Operating Expenses (2009 - 2026)

West Pharmaceutical Services has disclosed Operating Expenses across 18 years of filings, most recently posting $137.3 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 19.39% year-over-year to $137.3 million; the TTM figure through Jun 2026 stood at $501.2 million (up 18.74% YoY), while the FY2025 annual figure was $467.9 million, up 14.79% from the prior year.
• Operating Expenses came in at $137.3 million for Q2 2026 at West Pharmaceutical Services, up from $115.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $137.3 million in Q2 2026 to a low of $79.9 million in Q3 2022.
• Average Operating Expenses over 5 years is $107.0 million, with a median of $104.3 million recorded in 2024.
• Year-over-year, Operating Expenses dropped 23.9% in 2022 and soared 31.91% in 2023.
• Over 5 years, Operating Expenses stood at $101.6 million in 2022, then advanced by 6.69% to $108.4 million in 2023, then decreased by 4.24% to $103.8 million in 2024, then advanced by 24.08% to $128.8 million in 2025, then climbed by 6.6% to $137.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $137.3 million in Q2 2026, $115.3 million in Q1 2026, and $128.8 million in Q4 2025.